JSP191 (briquilimab)

briquilimab · Jasper Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JSP191 (briquilimab), covering 2025-02-27 to 2025-02-27. Get the full timeline:

Most recent: Clinical Trial Update: JSP191 (briquilimab) in Subjects with LR-MDS [Phase 1]